Zero ad trackers.We never sell your data.

Home / For clinicians / Conditions / Otolaryngology

Otolaryngology: rare disease drugs and conditions

Not a doctor or health care professional? This page is for clinicians.Go to the patient version

1 condition and 1 prescribing guide so far.

By specialty and condition

Each condition page compares its drugs side by side and lists FDA decisions, label changes and open trials.

Otolaryngology
Recurrent respiratory papillomatosis
1 prescribing guide · 1 other approved medicine listed
Compare the drugs →
Voceryq doruxapapogene

Prescribing guides

The first 90 days from the prescriber's side, built from the current label, the drugmaker's program and one public insurer policy.

Recurrent respiratory papillomatosis
Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd)Dosing, CELLECTRA, Surgery Timing, CoverageNo REMS, boxed warning or contraindications; surgical debulking of visible papilloma before dose 1; a CELLECTRA 5PSP device, requested from INOVIO at 1-855-INOVIO1, and a provider trained in its use; current height and weight for needle depth; a deltoid or anterolateral quadriceps site clear of an ipsilateral ICD or pacemaker, metal implants and skin abnormalities.Label October 30, 2026 · checked November 9, 2026